Company Parnell Pharmaceuticals Holdings Ltd

Equities

PARNF

AU0000XINEU9

Pharmaceuticals

Market Closed - OTC Markets 11:07:19 2023-12-22 am EST 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Parnell Pharmaceuticals Holdings Ltd -.--% -.--%

Business Summary

Parnell Pharmaceuticals Holdings Ltd is an Australia-based company, which is engaged in offering the global veterinary pharmaceutical business marketing products in 14 countries. The Company operates sterile manufacturing facilities and offers digital technology platforms that integrate with the Company’s products to offer veterinarians and animal owners superior solutions for their animal health needs. The Company also provides a fully integrated animal health platform. The Company’s mySYNCH is a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. The Company’s products include GONAbreed, estroPLAN, and RESPIRmycin. GONAbreed is used for the treatment of cystic ovaries and used in cattle synchronization protocols. The estroPLAN is used in animals with unobserved or non-detected estrus in cattle undergoing synchronization protocols. The RESPIRmycin is used for the treatment of respiratory disease in beef and non-lactating dairy cattle.

Sales per Business

USD in Million2017Weight2018Weight Delta
Production Animal - U.S.
41.2 %
7 48.0 % 8 41.2 % +16.22%
Manufacturing
38.9 %
3 22.7 % 8 38.9 % +131.78%
Companion Animal
11.9 %
3 17.1 % 2 11.9 % -5.90%
Production Animal - Rest of World
7.9 %
2 12.2 % 2 7.9 % -12.18%

Sales per region

USD in Million2017Weight2018Weight Delta
United States
84.0 %
11 77.7 % 17 84.0 % +46.20%
Australia
11.8 %
2 14.1 % 2 11.8 % +13.76%
Other Countries
2.6 %
1 6.7 % 1 2.6 % -46.85%
New Zealand
1.5 %
0 1.6 % 0 1.5 % +32.65%

Managers

Managers TitleAgeSince
Chief Executive Officer 48 10-01-31
Chief Tech/Sci/R&D Officer - 20-12-31
Chief Operating Officer - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 50 -
Director/Board Member - 20-12-20
Chief Executive Officer 48 10-01-31
Chairman 67 05-12-31
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,023,814 18,023,814 ( 100.00 %) 0 100.00 %

Company contact information

Parnell Pharmaceuticals Holdings Ltd.

Unit 4 Century Estate 476 Gardeners Road

2015, Sydney

+61 2 9667 4411

http://www.parnell.com
address Parnell Pharmaceuticals Holdings Ltd(PARNF)
  1. Stock Market
  2. Equities
  3. PARNF Stock
  4. Company Parnell Pharmaceuticals Holdings Ltd